PROMISE 2试验对Eptinezumab-jjmr的安全性评价结果显示,Eptinezumab-jjmr 100 和300 mg治疗组的患者中与治疗相关的不良反应事件发生率为13.2%,安慰剂组为7.9%,最常见的不良反应为恶心 [Eptinezumab-jjmr组,n=11 (1.6%);安慰剂组,n=1 (<1%)]和疲劳 [Eptinezumab-jjmr组,n=13 (1.8%);安慰剂组,n...
1.Diagnosis of episodic or chronic migraine;2.Provider’s attestation that m ember experiences ≥ 4 migraine days per month for at least 3 months;3.Age ≥ 18 years;4.Failure of at least 2 of the following oral migraine preventative therapies, each for 8 weeks and from different therapeutic ...
Pay as little as $0 for VYEPTI* Save up to $200 per infusion on their administration out-of-pocket cost* Offer includes 100 mg and up to 300 mg doses. ENROLL YOUR PATIENTS NOW *Your patient’s out-of-pocket cost may vary depending on their dose, insurance coverage, and eligibility....
To prepare a 100-mg dose, withdraw 1 mL of injection concentrate from a single-dose vial (containing 100 mg/mL of eptinezumab) and add to an infusion bag containing 100 mL of 0.9% sodium chloride injection.Mix by gentle inversion; donotshake. ...